2 factors are adversely affecting H1N1 vaccines at this moment....

2 factors are adversely affecting H1N1 vaccines at this moment. Firstly, it was rushed into production amidst much concern about its safety - hence a worldwide reluctance in the general public to become innoculated. This has lead to oversupply and order cancellations. Latter is accentuated by the fact that even in the best of times a specific vaccine typically has a product life cycle of 6 months before it needs to be tweaked (or completely revised) to meet the ever evolving influenza challenge.

Nice to see that the vaccine/anti-viral confusion is not confined to Australia.